2024-07-19
Innostar succefully assisted Signet Therapeutics in the IND approval by U.S. FDA of the world's first targeted drug for the treatment of diffuse gastric cancer
Innostar succefully assisted Signet Therapeutics in the IND approval by U.S. FDA of the world's first targeted drug for the treatment of diffuse gastric cancer
See more
